This study provides a comprehensive exploration of ALDH1A3’s multifaceted impact on breast cancer, elucidating its roles in CSC maintenance and tumor heterogeneity, EMT and MET, and metabolic reprogramming. Here, ALDH1A3 is linked to breast carcinoma.